Phase II study of PKC-α antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer
- Paul Ritch
- , Charles M. Rudin
- , Jacob David Bitran
- , Martin J. Edelman
- , Alex Makalinao
- , David Irwin
- , Rogerio Lilenbaum
- , Patrick Peterson
- , William J. John
- Medical College of Wisconsin
- University of Chicago
- Advocate Health Care
- University of Maryland Cancer Center
- California Hematology Oncology Medical Group
- Alta Bates Comprehensive Cancer Center
- Mount Sinai Medical Center Miami Beach
- Eli Lilly and Company
- Commonwealth Cancer Center
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations